MTHFD2 promotes esophageal squamous cell carcinoma progression via m6A modification‑mediated upregulation and modulation of the PEBP1‑RAF1 interaction. [PDF]
Zhou H+6 more
europepmc +1 more source
Abstract Chemoresistance and immune evasion remain significant barriers to effective esophageal cancer (EC) treatment. This study explores the mechanistic role of extracellular vesicles (EVs) delivering LncRNA HOTAIR in modulating these processes. Using transcriptomic profiling, LncRNA HOTAIR was identified as a critical factor in EC progression.
Tayier Tuersong+7 more
wiley +1 more source
Sevoflurane: A dual modulator of miR‑211‑5p and mitochondrial apoptosis in glioma therapy. [PDF]
Wang H+7 more
europepmc +1 more source
Selenium Nanoparticles in Cancer Therapy: Unveiling Cytotoxic Mechanisms and Therapeutic Potential
ABSTRACT Background Cancer represents a complex group of diseases characterized by abnormal cell proliferation, invasion, and metastasis. These features pose significant challenges to conventional therapeutic approaches, necessitating the development of more targeted and effective treatment strategies.
Sumaira Anjum+6 more
wiley +1 more source
The intersection of aging and estrogen in osteoarthritis. [PDF]
Atasoy-Zeybek A+4 more
europepmc +1 more source
Targeting the MDK/c‐Myc complex to overcome temozolomide resistance in glioma
ACT001 disrupts the MDK/c‐Myc complex, enhancing c‐Myc ubiquitination and overcoming temozolomide resistance in glioma. Combining ACT001 with temozolomide synergistically inhibits tumour growth and progression, offering a promising therapeutic strategy for glioma patients, particularly those with high MDK expression.
Xiaonan Xi+7 more
wiley +1 more source
Chronic intermittent hypoxia affects the expression of IRS - 2/p - Akt/GSK - 3 in the liver of SD rats and its impact on glucose metabolism. [PDF]
Wang H, Guo T.
europepmc +1 more source
(A) Post hoc pairwise comparisons between the four studied groups regarding the log2 of serum fold change of CircFUNDC1. There were significant differences between CRC, UC, or CD and controls. p values (Controls vs. UC = < 0.001, Controls vs. CD = < 0.001, Controls vs. CRC = < 0.001, UC vs. CD = 1.000, UC vs. CRC = 0.194, CD vs. CRC = 0.255).
Marwa A. Ali+12 more
wiley +1 more source
YY1-induced DDX18 modulates EMT via the AKT/mTOR pathway in esophageal cancer: a novel therapeutic target. [PDF]
Ma X+6 more
europepmc +1 more source